What is the address of ROBINET SEBASTIEN CARDIOLOGIE?

The registered office of ROBINET SEBASTIEN CARDIOLOGIE is located at Rue L. Maréchal 129, 4360 Oreye.

Is ROBINET SEBASTIEN CARDIOLOGIE still active?

Yes. According to the CBE (28 September 2026) ROBINET SEBASTIEN CARDIOLOGIE is active, legal situation “Normale toestand”, started on 11 August 2017.

Is ROBINET SEBASTIEN CARDIOLOGIE registered on Peppol?

Yes, ROBINET SEBASTIEN CARDIOLOGIE is registered on the Peppol network with ID 0208:0679774812.

What is the enterprise number of ROBINET SEBASTIEN CARDIOLOGIE?

The enterprise number of ROBINET SEBASTIEN CARDIOLOGIE is BE0679774812.

When was ROBINET SEBASTIEN CARDIOLOGIE founded?

ROBINET SEBASTIEN CARDIOLOGIE was founded on 11 August 2017.

Who are the directors of ROBINET SEBASTIEN CARDIOLOGIE?

According to the 2025 annual accounts, the directors of ROBINET SEBASTIEN CARDIOLOGIE are: Sébastien ROBINET.

Is ROBINET SEBASTIEN CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 August 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ROBINET SEBASTIEN CARDIOLOGIE make in 2025?

ROBINET SEBASTIEN CARDIOLOGIE posted a profit after taxes of € 224,525 in financial year 2025.

What is the revenue of ROBINET SEBASTIEN CARDIOLOGIE?

As a small company, ROBINET SEBASTIEN CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 361,092.

ROBINET SEBASTIEN CARDIOLOGIE (Private Limited) - Oreye

Dossier ROBINET SEBASTIEN CARDIOLOGIE, printed on 28 September 2026 from databakkes.be/en/0679774812/robinet-sebastien-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ROBINET SEBASTIEN CARDIOLOGIE from Oreye, company number BE0679774812, closed financial year 2025 with a result of € 224,525 after tax. For that financial year ROBINET SEBASTIEN CARDIOLOGIE recorded a gross margin of € 361,092 and equity of € 20,716. Compared with financial year 2024, the result moved from € 135,429 to € 224,525. Profitable, and profit is growing. The buffer shrank hard: equity is 87 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Shrank hard

€ 20,716

▼ 87% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 224,525

▲ 66% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 165,454

▲ € 133,195 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 360,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 51,258

▲ 59% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 55,535

€ 12,593 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 8,866

▼ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 85

▼ 98% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 198,628 Gross margin 2022: € 198,628 First fiscal year in the series	€ 211,774 Gross margin 2023: € 211,774 ▲ 7% vs 2022 (€ 198,628) Favourable step	€ 222,420 Gross margin 2024: € 222,420 ▲ 5% vs 2023 (€ 211,774) Favourable step	€ 361,092 Gross margin 2025: € 361,092 ▲ 62% vs 2024 (€ 222,420) Favourable step	▲ 62%
Profit after taxes	€ 136,561 Profit after taxes 2022: € 136,561 First fiscal year in the series	€ 131,740 Profit after taxes 2023: € 131,740 ▼ 4% vs 2022 (€ 136,561) Unfavourable step	€ 135,429 Profit after taxes 2024: € 135,429 ▲ 3% vs 2023 (€ 131,740) Favourable step	€ 224,525 Profit after taxes 2025: € 224,525 ▲ 66% vs 2024 (€ 135,429) Favourable step	▲ 66%
Equity	€ 157,021 Equity 2022: € 157,021 First fiscal year in the series	€ 288,762 Equity 2023: € 288,762 ▲ 84% vs 2022 (€ 157,021) Favourable step	€ 156,191 Equity 2024: € 156,191 ▼ 46% vs 2023 (€ 288,762) Unfavourable step	€ 20,716 Equity 2025: € 20,716 ▼ 87% vs 2024 (€ 156,191) Unfavourable step	▼ 87%
Total debts	€ 89,090 Total debts 2022: € 89,090 First fiscal year in the series	€ 13,057 Total debts 2023: € 13,057 ▼ 85% vs 2022 (€ 89,090) Favourable step	€ 195,128 Total debts 2024: € 195,128 ▲ € 182,071 vs 2023 (€ 13,057) Unfavourable step	€ 556,147 Total debts 2025: € 556,147 ▲ 185% vs 2024 (€ 195,128) Unfavourable step	▲ 185%
Cash	€ 44,073 Cash 2022: € 44,073 First fiscal year in the series	€ 28,076 Cash 2023: € 28,076 ▼ 36% vs 2022 (€ 44,073) Unfavourable step	€ 32,259 Cash 2024: € 32,259 ▲ 15% vs 2023 (€ 28,076) Favourable step	€ 165,454 Cash 2025: € 165,454 ▲ € 133,195 vs 2024 (€ 32,259) Favourable step	▲ € 133,195
Retained profit	€ 138,421 Retained profit 2022: € 138,421 First fiscal year in the series	€ 268,302 Retained profit 2023: € 268,302 ▲ 94% vs 2022 (€ 138,421) Favourable step	€ 135,731 Retained profit 2024: € 135,731 ▼ 49% vs 2023 (€ 268,302) Unfavourable step	€ 256 Retained profit 2025: € 256 ▼ € 135,475 vs 2024 (€ 135,731) Unfavourable step	▼ € 135,475
Dividend	€ 357,188 Dividend 2022: € 357,188 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 357,188) Unchanged	€ 268,000 Dividend 2024: € 268,000 Unchanged (€ 0) Unchanged	€ 360,000 Dividend 2025: € 360,000 ▲ 34% vs 2024 (€ 268,000) Unchanged	▲ 34%
Bank debt	€ 11,593 Bank debt 2022: € 11,593 First fiscal year in the series	€ 5,836 Bank debt 2023: € 5,836 ▼ 50% vs 2022 (€ 11,593) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 5,836) Favourable step	€ 55,535 Bank debt 2025: € 55,535 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 246,111 Balance sheet total 2022: € 246,111 First fiscal year in the series	€ 301,818 Balance sheet total 2023: € 301,818 ▲ 23% vs 2022 (€ 246,111) Unchanged	€ 351,319 Balance sheet total 2024: € 351,319 ▲ 16% vs 2023 (€ 301,818) Unchanged	€ 576,863 Balance sheet total 2025: € 576,863 ▲ 64% vs 2024 (€ 351,319) Unchanged	▲ 64%

Key figures of ROBINET SEBASTIEN CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ROBINET SEBASTIEN CARDIOLOGIE?

What happened at ROBINET SEBASTIEN CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 224,525 (▲ 66% vs 2024). Source: NBB ↗
Aug 11, 2017 New establishment in Oreye. KBO
Aug 11, 2017 Start of the company according to the CBE. KBO

In short

From € 136,561 profit in 2022 to € 224,525 profit in 2025.

Paid € 213,647 in corporate taxes since 2022.

Best year ever: 2025, with € 224,525 profit.

Paid out € 985,188 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at ROBINET SEBASTIEN CARDIOLOGIE? We notify you, reason included.

Follow ROBINET SEBASTIEN CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sébastien ROBINET

ROBINET SEBASTIEN CARDIOLOGIE

Behind ROBINET SEBASTIEN CARDIOLOGIE is Sébastien ROBINET.

See the full network in the app

Directors

According to the 2025 annual accounts

Sébastien ROBINET

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue L. Maréchal 129

4360 Oreye

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0679.774.812
VAT number: BE 0679.774.812
Registered office: Rue L. Maréchal 129, 4360 Oreye
Names & denominations: ROBINET SEBASTIEN CARDIOLOGIE · RSCardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 August 2017
Peppol: Active · Active since 15 Sept 2026

View on CBE Public ↗ Annual accounts (NBB) ↗